| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/29/2004 | EP1490495A2 Bone generation by gene therapy |
| 12/29/2004 | EP1490494A1 Method of designing synthetic nucleic acid sequences for optimal protein expression in a host cell |
| 12/29/2004 | EP1490492A2 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
| 12/29/2004 | EP1490491A2 Use of the protein maba (fabg1) of i mycobacterium tuberculosis /i for designing and screening antibiotics |
| 12/29/2004 | EP1490483A2 In vivo incorporation of unnatural amino acids |
| 12/29/2004 | EP1490482A1 Host cells having improved cell survival properties and methods to generate such cells |
| 12/29/2004 | EP1490481A2 Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media |
| 12/29/2004 | EP1490406A1 Costimulatory molecule and its use |
| 12/29/2004 | EP1490404A1 Lactoferrin |
| 12/29/2004 | EP1490402A1 Preparation of g-csf stoichiometrically conjugated with biocompatible polymers at cystein residue |
| 12/29/2004 | EP1490401A1 Vegf peptides and their use |
| 12/29/2004 | EP1490400A2 Tenascin-w compositions and uses thereof |
| 12/29/2004 | EP1490399A2 Human diabetes-mediating proteins |
| 12/29/2004 | EP1490398A2 Tumour associated antigens |
| 12/29/2004 | EP1490397A1 Novel bacillus thuringiensis insecticidal proteins |
| 12/29/2004 | EP1490396A2 Immunogenic hiv peptides for use as reagents and vaccines |
| 12/29/2004 | EP1490395A1 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity |
| 12/29/2004 | EP1490389A2 Hepatitis c virus sub-genomic replicons |
| 12/29/2004 | EP1490388A1 Novel compositions and methods in cancer associated with altered expression of kcnj9 |
| 12/29/2004 | EP1490386A2 Novel polypeptides and nucleic acids encoding the same |
| 12/29/2004 | EP1490381A1 Human gene critical to fertility |
| 12/29/2004 | EP1490112A1 Method and agent for producing therapeutically active blood compositions |
| 12/29/2004 | EP1490110A2 Anti-alpha v beta 6 antibodies |
| 12/29/2004 | EP1490109A2 Egfr ligands and methods of use |
| 12/29/2004 | EP1490108A2 Drg11-responsive (dragon) gene family |
| 12/29/2004 | EP1490105A2 Multiple and multivalent dna vaccines in ovo |
| 12/29/2004 | EP1490101A1 Methods of enhancing immune induction involving mda-7 |
| 12/29/2004 | EP1490094A1 Antibody fusion proteins: effective adjuvants of protein vaccination |
| 12/29/2004 | EP1490089A1 Peptides selectively lethal to malignant and transformed mammalian cells |
| 12/29/2004 | EP1490087A2 Self-assembling-peptide-based structures and processes for controlling the self-assembly of such structures |
| 12/29/2004 | EP1490086A2 Use of an organ-specific self-pathogen for treatment of a non-autoimmune disease of said organ |
| 12/29/2004 | EP1490085A2 Fc receptor homolog, reagents, and uses thereof |
| 12/29/2004 | EP1490084A2 Compositions and methods for regulating thyroid hormone metabolism and cholesterol and lipid metabolism via the nuclear receptor car |
| 12/29/2004 | EP1408736A4 Plants characterized by enhanced growth and methods and nucleic acid constructs useful for generating same |
| 12/29/2004 | EP1397036A4 Xrcc1 and uses thereof |
| 12/29/2004 | EP1379140A4 Production of pancreatic islet cells and delivery of insulin |
| 12/29/2004 | EP1295230A4 Method and system for foreign exchange price procurement and automated hedging |
| 12/29/2004 | EP1294929A4 Method to detect modulators of vegf kinase domain |
| 12/29/2004 | EP1284998B1 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 12/29/2004 | EP1278883B1 E. coli extract for protein synthesis |
| 12/29/2004 | EP1255852A4 Immunoassay and diagnostic reagent for malaria |
| 12/29/2004 | EP1196616B1 Replication-competent anti-cancer vectors |
| 12/29/2004 | EP1196581B1 Promoter expressed specifically in the cells of plant roots, recombinant vectors and host cells comprising same and transgenic plants obtained |
| 12/29/2004 | EP1161456B1 Ccr5 binding antibody constructs and their use for treating autoimmune diseases |
| 12/29/2004 | EP1146909A4 Method of treating cancer by restoration of pp32 function |
| 12/29/2004 | EP1090033B1 Particles of hcv envelope proteins: use for vaccination |
| 12/29/2004 | EP1084251B1 Attenuated pestiviruses |
| 12/29/2004 | EP1066375B1 $i(LACTOBACILLI) HARBORING AGGREGATION AND MUCIN BINDING GENES AS VACCINE DELIVERY VEHICLES |
| 12/29/2004 | EP1066045B1 Mammalian-derived peptides for the treatment of microbial infection |
| 12/29/2004 | EP1033953A4 Method of cross-linking keratin-based films, sheets, and bulk materials |
| 12/29/2004 | EP1027372B1 Methods, kits and compositions pertaining to linear beacons |
| 12/29/2004 | EP1011720B1 Mucosal cytotoxic t lymphocyte responses |
| 12/29/2004 | EP0996709B1 Inhibitors of cellulolytic, xylanolytic and beta-glucanolytic enzymes |
| 12/29/2004 | EP0959975B1 Novel affinity ligands and their use |
| 12/29/2004 | EP0954527B1 Glycine transporter-transfected cells and uses thereof |
| 12/29/2004 | EP0935651B1 THERAPY FOR alpha-GALACTOSIDASE A DEFICIENCY |
| 12/29/2004 | EP0890361B1 HGF mutant and its use as an anticancer agent |
| 12/29/2004 | EP0868431B1 Protein with plant protecting properties |
| 12/29/2004 | EP0858505B1 Cloning of vertebrate pheromone receptors and uses thereof |
| 12/29/2004 | EP0830130B9 Tnf-alpha converting enzyme |
| 12/29/2004 | EP0785946B1 Materials for the production of nanometer structures and use thereof |
| 12/29/2004 | EP0725792B1 PROCESS FOR PRODUCING RECOMBINANT PilC PROTEINS |
| 12/29/2004 | EP0653940B1 Glial mitogenic factors, their preparation and use |
| 12/29/2004 | EP0623172B1 Marek's disease virus recombinant vaccinia virus vaccine |
| 12/29/2004 | CN1559007A Assay for paralytic shellfish toxin |
| 12/29/2004 | CN1558952A Pegylated and diglycosylated erythropoietin |
| 12/29/2004 | CN1558916A Compositions and methods for generating chimeric heteromultimers |
| 12/29/2004 | CN1558915A Leukocyte inactivation module |
| 12/29/2004 | CN1558914A Receptor, the use thereof, and mouse antibodies |
| 12/29/2004 | CN1558913A Novel genetic products obtained from ashbya gossypii, which are associated with transcription mechanisms, RNA processing and/or translation |
| 12/29/2004 | CN1558912A Method for making acylated polypeptides |
| 12/29/2004 | CN1558775A Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases |
| 12/29/2004 | CN1558774A Angiotensin peptide-carrier conjugates and uses thereof |
| 12/29/2004 | CN1558772A Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone |
| 12/29/2004 | CN1558762A Novel ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer |
| 12/29/2004 | CN1557952A Solanum lycopersicoides dun. S1Ve1 receptor protein encoding sequence and use thereof |
| 12/29/2004 | CN1557950A Method of preparing lactoferritin and lactoperoxidase |
| 12/29/2004 | CN1557835A Pituitary adenylate cyclase activated polypeptide derivatives and process for preparing the same |
| 12/29/2004 | CN1557480A Preparation and application of insulin-like growth factors |
| 12/29/2004 | CN1557281A Skin apolexis preventing delaying polypeptide and compositions |
| 12/29/2004 | CN1182399C Removal of prions from blood, plasma and other liquids |
| 12/29/2004 | CN1182243C Technique method for preparing nitrile hydratase by using glucose-CO2+ coupling adding ferment |
| 12/29/2004 | CN1182155C Recombinant human hepatocyte auxin, its preparing process and its clinical application |
| 12/29/2004 | CN1181890C Use of enterobacterium protein OmpA in the preparation of antigen presentation cells specified targeting medicine |
| 12/29/2004 | CN1181887C Recombinant gamma-interferon for preventing and treating cow's recessive mammitis |
| 12/29/2004 | CN1181886C Application of TNF-derived peptides in the treatment of oedema |
| 12/29/2004 | CN1181885C Administration of polypeptide growth factors after central nervous system ischemia or trauma |
| 12/29/2004 | CA2570502A1 Castanea sativa mill. genes codifying for allene oxide cyclase, cystatin, beta-1,3-glucanase and thaumatin-like protein and their use |
| 12/29/2004 | CA2570464A1 Use of cardiotrophin to modulate stem cell proliferation |
| 12/29/2004 | CA2570407A1 Methods and compositions for modulating stem cell growth and differentiation |
| 12/29/2004 | CA2534748A1 Relaxin superfamily peptide analogues |
| 12/29/2004 | CA2530049A1 Methods and means for delaying seed shattering in plants |
| 12/29/2004 | CA2530043A1 Modulation of coffee flavour precursor levels in green coffee grains |
| 12/29/2004 | CA2529997A1 Novel surface protein (hbsag) variant of hepatitis b virus |
| 12/29/2004 | CA2529986A1 Novel surface protein (hbsag) variant of hepatitis b virus |
| 12/29/2004 | CA2529882A1 Cell line and uses thereof |
| 12/29/2004 | CA2529838A1 Isoforms of eif-5a: senescence-induced eif5a; wounding-induced eif-5a; growth eif-5a; and dhs |
| 12/29/2004 | CA2529639A1 Detection of survivin in the biological fluids of cancer patients |
| 12/29/2004 | CA2529587A1 Plant transcriptional activator and uses thereof |
| 12/29/2004 | CA2529565A1 Modified bordetella adenylate cyclase comprising or lacking cd11b/cd18 interaction domain and uses thereof |